Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3

Journal of Thoracic and Cardiovascular Surgery

Volumn 135, Issue 3, 2008, Pages 615-619

  Lee, Benjamin Enoch ^a   Redwine, Jonathon ^a   Foster, Cameron ^b   Abella, Elma ^c   Lown, Teri ^a   Lau, Derick ^b   Follette, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Northern California PET Imaging Ctr   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER CENTER; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 40149086957     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.09.029     Document Type: Article

References (21)

1. Jemal A., Siegal R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2007) 106-130
2. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
3. Cerfolio R.J., Ojha B., Bryant A.S., Raghuveer V., Mountz J.M., and Bartolucci A.A. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg 78 (2004) 1017-1023
4. Halpern B.S., Schiepers C., Weber W.A., Crawford T.L., Fueger B.J., Phelps M.E., et al. Presurgical staging on non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 128 (2005) 2289-2297
5. Roberts P.F., Follette D.M., Von Haag D.W., Park J.A., Valk P.E., Pounds T.R., et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 70 (2000) 1154-1160
6. Takamochi K., Yoshida J., Murakami K., Niho S., Ishii G., Nishimura M., et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 47 (2005) 235-242
7. Lee B.E., Von Haag D.W., Lown T., Lau D., Calhoun R., and Follette D. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer. J Thorac Cardiovasc Surg 133 (2007) 746-752
8. Gonzalez-Stawinski G.V., Lemaire A., Merchant F., O'Halloran E., Coleman R.E., Harpole D.H., et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg 126 (2003) 1900-1904
9. Lemaire A., Nikolic I., Petersen T., Haney J.C., Toloza E.M., Harpole D.H., et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg 82 (2006) 1185-1189
10. Cerfolio R.J., Bryant A.S., Ohja B., and Bartolucci A.A. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence and survival. J Thorac Cardiovasc Surg 130 (2005) 151-159
11. Vesselle H., Turcotte E., Wiens L., Schmidt R., Takasugi J.E., Lalani T., et al. Relationship between non-small cell lung cancer fluorodeoxyglucose uptake at positron emission tomography and surgical stage with relevance to patient prognosis. Clin Cancer Res 10 (2004) 4709-4716
12. Bryant A.S., Cerfolio R.J., Klemm K.M., and Ojha B. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg 82 (2006) 417-422
13. Nabi H.A., and Zubeldia J.M. Clinical applications of F18-FDG in oncology. J Nucl Med Technol 30 (2002) 3-9
14. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
15. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
16. Micames C.G., McCrory D.C., Pavey D.A., Jowell P.S., and Gress F.G. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis. Chest 131 (2007) 539-548
17. Annema J.T., Versteegh M.I., Veselic M., Welker L., Mauad T., Sont J.K., et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA 294 (2005) 931-936
18. Rusch V.W. Mediastinoscopy: an endangered species?. J Clin Oncol 23 (2005) 8283-8285
19. Grunenwald D.H., and Albain K.S. The potential role of surgery after induction treatment. Semin Radiat Oncol 14 (2004) 335-339
20. Cerfolio R.J., and Bryant A.S. Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with non-small cell lung cancer. Ann Thorac Surg 83 (2007) 1826-1830
21. Chung J.H., Lee W.W., Park S.Y., Choe G., Sung S.W., Chung J.K., et al. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer. Eur J Surg Oncol 32 (2006) 989-995